Načítá se...
Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy
RNA interference (RNAi) offers a promising therapeutic approach for dominant genetic disorders that involve gain-of-function mechanisms. One candidate disease for RNAi therapy application is myotonic dystrophy type 1 (DM1), which results from toxicity of a mutant mRNA. DM1 is caused by expansion of...
Uloženo v:
| Vydáno v: | Hum Mol Genet |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4527493/ https://ncbi.nlm.nih.gov/pubmed/26082468 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddv219 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|